The U.S. Food and Drug Administration has announced the recall of Ferrari Chocolates because of undeclared peanuts and possible fungi contamination.
The FDA said the candy, a product of China that was distributed by Tristar Food Wholesale of Jersey City, N.J., presents a serious or life-threatening health risk for people who have an allergic sensitivity to peanuts.
The FDA said the candy also contains excess amounts of aflatoxins -- by-products of certain fungi that can be potential carcinogens.
The recalled Ferrari Chocolates were distributed in 280-gram and 240-gram boxes in New York City and New Jersey.
Consumers can contact the company at 201-938-2590.
Copyright 2007 by United Press International
Related stories:
More aortic chest aneurysms being treated with less-invasive stents
An estimated 60,000 Americans are walking around with time bombs in their chests called thoracic aortic aneurysms. At any time, their main chest artery could suddenly burst open, causing massive internal bleeding that is almost always fatal.
Ferrari to slash sports cars' carbon emissions: president
Sports car manufacturer Ferrari intends to cut its vehicles' greenhouse gas emissions by nearly half and is working on developing hybrid vehicles, the company president said Saturday.
Vitamin D in brain function
In a definitive critical review, scientists at Children’s Hospital & Research Center Oakland ask whether there is convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction. Joyce C. McCann, Ph.D., assistant staff scientist and Bruce N. Ames, Ph.D., senior scientist at Children’s Hospital Oakland Research Institute (CHORI) conclude that there is ample biological evidence to suggest an important role for vitamin D in brain development and function, and that supplementation for groups chronically low in vitamin D is warranted. Their conclusions will be published on April 22, 2008 in the Federation of American Societies for Experimental Biology (FASEB) Journal.
Nanomedicine system engineered to enhance therapeutic effects of injectable drugs
In an article featured on the cover of the March issue of
Nature Nanotechnology, Mauro Ferrari, Ph.D., of The University of Texas Health Science Center at Houston presented a proof-of-concept study on a new multistage delivery system (MDS) for imaging and therapeutic applications. This discovery could go a long way toward making injectable drugs more effective.
Heart attack rates fall following national smoking bans
French researchers announced a striking 15% decrease in admissions of patients with myocardial infarction to emergency wards since the public ban on smoking came into effect in restaurants, hotels and casinos in France last January. The announcement was made on 23 February by the National Sanitary Institute. Similar results were published in Italy on 12 February by the Environmental Health Authority: researchers in Rome found an 11.2 percent reduction of acute coronary events since the January 2005 smoking ban took effect in Italy.
Dry season brings on measles in sub-Saharan Africa
Measles epidemics in Niger fluctuate wildly from one season to another but the timing of the outbreaks always coincides with the end of the annual rainy season, according to an international team of researchers.
Study finds genetic testing may help people with severe type of migraine
People with a severe type of migraine in which one side of the body becomes weak should consider genetic testing, according to research that has found familial genes for this type of migraine in people who did not have family members experiencing the problem. The findings are published in the December 4, 2007, issue of
Neurology, the medical journal of the American Academy of Neurology.
Microbiologist hits pay dirt
The current edition of science journal
Nature describes how Macquarie University microbiologist Dr Belinda Ferrari has been the first scientist worldwide to culture a particular family of bacteria in the lab, by growing it in mud instead of the traditional agar solution.